Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Dignass

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special SituationsPaolo Gionchetti, Axel Dignass, Silvio Danese, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
Inflammatory Bowel Diseases|November 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by AgeAdam S Faye, David T Rubin, Corey A Siegel, et al.
Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.
Nature Reviews. Gastroenterology & Hepatology|April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health responseVirginia Solitano, Charles N Bernstein, Iris Dotan, et al.
Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special SituationsPaolo Gionchetti, Axel Dignass, Silvio Danese, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
Inflammatory Bowel Diseases|November 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by AgeAdam S Faye, David T Rubin, Corey A Siegel, et al.
Journal of Crohn'S & Colitis|June 27, 2025
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY surveyGionata Fiorino, Catarina Fidalgo, Michel Adamina, et al.
Nature Reviews. Gastroenterology & Hepatology|April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health responseVirginia Solitano, Charles N Bernstein, Iris Dotan, et al.
Journal of Crohn'S & Colitis|June 13, 2025
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY surveyGionata Fiorino, Alissa Walsh, Michel Adamina, et al.
Pageof 18